APH vs IRD · P/E 40, rev $23.09B vs rev $11.0M
Amphenol Corporation (APH) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. IRD currently screens at market cap $35.7M.
Not investment advice. Open the APH and IRD stock pages for the full models.
Not investment advice.